Patient Preferences with Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: A Multinational Discrete Choice Experiment Study
Patient preferences for treatment are driven by several factors. Considering these preferences is essential when designing/introducing new therapies. Individual treatment preferences should be identified and given key consideration when helping patients select from an expanding array of treatment options.
Authors
- Carl J. Danzig (ORCID: https://orcid.org/0000-0002-7422-802X)
- Alfredo García‐Layana (ORCID: https://orcid.org/0000-0001-5732-2797)
- Mariacristina Parravano (ORCID: https://orcid.org/0000-0002-2223-7311)
- Mirela Mirt
- Laurent Kodjikian (ORCID: https://orcid.org/0000-0002-3908-6716)
- David R. Chow (ORCID: https://orcid.org/0000-0002-6299-0156)
- Liliana P Paris (ORCID: https://orcid.org/0000-0002-9312-9924)
- Brittany Gentile (ORCID: https://orcid.org/0000-0002-6302-5593)
- Timothy L. Jackson (ORCID: https://orcid.org/0000-0001-7618-1555)
- Mickael Henry-Szatkowski
- C. Gloria (ORCID: https://orcid.org/0000-0001-5657-5979)
- Hannah B Lewis (ORCID: https://orcid.org/0000-0002-6780-4965)
Institutions
- Université Claude Bernard Lyon 1 (FR)
- Roche (Switzerland) (CH)
- Centre National de la Recherche Scientifique (FR)
- King's College London (GB)
- Patient-Centered Outcomes Research Institute (US)
- Hospices Civils de Lyon (FR)
- Fondazione G.B. Bietti (IT)
- Matériaux Ingénierie et Science (FR)
- Clinica Universidad de Navarra (ES)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- East Florida Eye Institute (US)
- Institut National des Sciences Appliquées de Lyon (FR)
Publication Details
- Journal
- Ophthalmic Research
- Published
- 2024-11-21
- DOI
- https://doi.org/10.1159/000541349
- Citations
- 3
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.62
Funders
- Genentech